Social networks
54,421 3,098Activities
Technologies
Entity types
Location
Windrush Court, Watlington Rd, Oxford OX4 6LT, UK
Oxford
United Kingdom
Employees
Scale: 501-1000
Estimated: 934
Engaged catalyst
20Added in Motherbase
4 years, 3 months agoOXB (LSE: OXB) is a global quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life changing therapies to patients around the world.
One of the original pioneers in cell and gene therapy, OXB has over 30 years of experience in viral vectors; the driving force behind the majority of cell and gene therapies. OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV), adenovirus and other viral vector types. OXB’s world-class capabilities range from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.
OXB offers a vast number of technologies for viral vector manufacturing, including a 4th generation lentiviral vector system (the TetraVectaTM system), a dual-plasmid system for AAV production, suspension and perfusion process using process enhancers and stable producer and packaging cell lines.
OXB, a FTSE250 and FTSE4Good constituent, is headquartered in Oxford, UK. It has development and manufacturing facilities across Oxfordshire, UK, Lyon and Strasbourg, France, Bedford MA, and Durham NC, US. Learn more at www.oxb.com and follow us on LinkedIn and YouTube.
Gene therapy, Immunotherapy, Viral vector GMP manufacturing, Cell and gene therapy, Lentiviral Vectors, AAV, Cell therapy, CDMO, GMP, Process Development, Manufacturing, and Advanced Therapies
25+ years enabling the world’s most progressive and successful viral vector therapies. Full service offering, supported by robust quality systems.
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research (Auto) |
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research (Auto) |
Other
27 Jul 2026 |
|
|
Ville et Eurométropole de Strasbourg
National and local authorities, Government Administration (Auto), French Metropolis |
Ville et Eurométropole de Strasbourg
National and local authorities, Government Administration (Auto), French Metropolis |
Other
1 Jul 2024 |
|
|
BioValley France
Public business cluster, Biotechnology, French Cluster, Biotechnology (Auto) |
BioValley France
Public business cluster, Biotechnology, French Cluster, Biotechnology (Auto) |
Other
24 Mar 2026 |
|
|
Oxford University Innovation
Research, Investment Management (Auto) |
Oxford University Innovation
Research, Investment Management (Auto) |
Other
22 May 2024 |
|
|
IP Group plc
Financial Services (Auto) |
IP Group plc
Financial Services (Auto) |
Other
30 Jun 2023 |
|
|
MSD
Pharmaceutical, Pharmaceutical Manufacturing (Auto) |
MSD
Pharmaceutical, Pharmaceutical Manufacturing (Auto) |
Other
2 Dec 2020 |
|
|
UK Research and Innovation
Public business cluster, Research Services (Auto) |
UK Research and Innovation
Public business cluster, Research Services (Auto) |
Other
6 May 2021 |
|
|
Illumina For Startups
Startup accelerator & VC, Biotechnology, Biotechnology Research (Auto) |
Illumina For Startups
Startup accelerator & VC, Biotechnology, Biotechnology Research (Auto) |
Other
12 Jun 2020 |
|
|
Raytheon
Biotechnology, Defense and Space Manufacturing (Auto) |
Raytheon
Biotechnology, Defense and Space Manufacturing (Auto) |
Other
29 Apr 2019 |
|
|
Apple
Consumer Electronics, Computers and Electronics Manufacturing (Auto) |
Apple
Consumer Electronics, Computers and Electronics Manufacturing (Auto) |
Other
8 Jun 2018 |
|
|